Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections

NCT06549530 is registered in ClinicalTrials.gov with Bavarian Nordic as lead sponsor.

NCT NCT06549530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06549530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter Immunogenicity and Safety Study of MVA-BN Vaccine in Children From 2 Years to Less Than 12 Years of Age Compared to Adults for the Prevention of Smallpox, Mpox, and Related Orthopoxvirus Infections
Lead sponsor
Bavarian Nordic
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 21, 2024
Completion date
May 7, 2026
Enrollment
460 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

monkeypox (mpox)